Bruce C Cozadd's Sale of Jazz Pharmaceuticals Shares

Bruce C Cozadd, Chairman & CEO of Jazz Pharmaceuticals plc, sold 1,000 ordinary shares on August 1, 2025, at a price of $113.21 per share. This transaction was executed under a Rule 10b5-1 trading plan, which allows company insiders to sell shares at predetermined times to avoid accusations of insider trading. Following this transaction, Cozadd's total ownership in Jazz Pharmaceuticals stands at 435,973 ordinary shares. The filing was signed by Paz Dizon as attorney in fact for Bruce C Cozadd.